WallStreetZenWallStreetZen

NYSE: CLB
Core Laboratories Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Core Laboratories revenue was $523.85M for the trailing 12 months ending Dec 31, 2024, with -12.7% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $129.2M, down 3.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CLB annual revenue was $523.8M, with 2.8% growth year-over-year.

CLB past revenue growth

How has CLB's revenue growth performed historically?

Company
2.76%
Industry
10.58%
Market
20.68%
CLB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CLB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CLB revenue history

Current Revenue
$523.8M
Current Earnings
$31.4M
Current Profit Margin
6%
CLB's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when CLB announces revenue.

CLB Revenue History By Year

CLB Yearly RevenueCLB RevenueCLB ChangeCLB Revenue Growth
2024-12-31$523.85M$14.06M+2.76%
2023-12-31$509.79M$20.06M+4.10%
2022-12-31$489.74M$19.48M+4.14%
2021-12-31$470.25M-$17.02M-3.49%
2020-12-31$487.27M-$180.94M-27.08%
2019-12-31$668.21M-$32.64M-4.66%
2018-12-31$700.85M$53.03M+8.19%
2017-12-31$647.82M$57.59M+9.76%
2016-12-31$590.23M-$207.29M-25.99%
2015-12-31$797.52M-$287.70M-26.51%
2014-12-31$1.09B$11.71M+1.09%
2013-12-31$1.07B$92.43M+9.42%
2012-12-31$981.08M$73.43M+8.09%
2011-12-31$907.65M$113.00M+14.22%
2010-12-31$794.65M$99.11M+14.25%
2009-12-31$695.54M-$85.30M-10.92%
2008-12-31$780.84M$110.30M+16.45%
2007-12-31$670.54M$94.85M+16.48%
2006-12-31$575.69M$92.22M+19.08%
2005-12-31$483.47M$56.04M+13.11%
2004-12-31$427.43M$54.26M+14.54%
2003-12-31$373.17M$42.40M+12.82%
2002-12-31$330.77M-$45.80M-12.16%
2001-12-31$376.57M$35.64M+10.45%
2000-12-31$340.93M$15.11M+4.64%
1999-12-31$325.83M$8.71M+2.75%
1998-12-31$317.12M$81.71M+34.71%
1997-12-31$235.41M$124.06M+111.41%
1996-12-31$111.35M$23.76M+27.13%
1995-12-31$87.59M$61.68M+238.07%
1994-12-31$25.91MN/AN/A

1 of 3

Core Laboratories Revenue FAQ

What was CLB's revenue last quarter?

Core Laboratories (NYSE: CLB) reported Q4 2024 revenue of $129.24 million up 0.8% year over year. In the same quarter last year, Core Laboratories's revenue was $128.21 million.

What was Core Laboratories's revenue in 2024?

Core Laboratories's annual revenue for the twelve months ending Dec 31, 2024 was $523.85 million, a 2.76% increase year over year.

How much does Core Laboratories make in a day?

Based on Core Laboratories annual revenue for the past five years, CLB makes an average of $1,359,392.88 per day.

What was Core Laboratories's annual revenue growth in the past year?

As of Q2 2025, Core Laboratories's revenue has grown 2.76% year over year. This is 7.82 percentage points lower than the US Oil & Gas Equipment & Services industry revenue growth rate of 10.58%. Core Laboratories's revenue in the past year totaled $523.85 million.

How much does Core Laboratories make in a year?

Core Laboratories's revenue by year for the past five years is:
  • Core Laboratories's revenue for the twelve months ending Dec 31, 2024 was $523.85 million, a 2.76% increase year over year.
  • Core Laboratories's annual revenue for Dec 31, 2023 was $509.79 million, a 4.1% increase from 2022.
  • Core Laboratories's annual revenue for 2022 was $489.74 million, a 4.14% increase from 2021.
  • Core Laboratories's annual revenue for 2021 was $470.25 million, a 3.49% decrease from 2020.
  • Core Laboratories's annual revenue for 2020 was $487.27 million, a 27.08% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.